RE-BVS – Piemonte Repository

Sfoglia per AUTORE
KEMP CN
Collezione AOU San Luigi di Orbassano

Items : 3

Nilotinib versus imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd 4-year (y) update in Journal of Clinical Oncology

2013
AOU San Luigi di Orbassano

Larson RA; Hochhaus A; Saglio G; Kim D-W; Jootar S; Le Coutre PD; Reiffers J; Pasquini R; Goldberg SL; Clark RE; Kemp CN; Fan X; Menssen HD; Hughes TP; Kantarjian HM;

Impact of early molecular response to nilotinib (NIL) or imatinib (IM) on the long-term outcomes of newly diagnosed patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): Landmark analysis of 4-year (y) data from ENESTnd in Journal of Clinical Oncology

2013
AOU San Luigi di Orbassano

Saglio G; Hughes TP; Larson RA; Issaragrilsil S; Turkina AG; Steegmann JL; Lopez JL; Nakaseko C; Kalaycio ME; Huguet F; Kemp CN; Fan X; Menssen HD; Kantarjian HM; Hochhaus A;

Nilotinib versus imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd 3-year (yr) follow-up (f/u) in Journal of Clinical Oncology

2012
AOU San Luigi di Orbassano

Kantarjian H; Flinn IW; Goldberg S; Bunworasate U; Zanichelli MA; Nakamae H; Hughes TP; Hochhaus A; Saglio G; Woodman RC; Blakesley RE; Kemp CN; Kalaycio ME; Larson RA;